GlassScriptPhysician profile
Samuel Mcarthur
NPI 1154577146
$7,564.58
in general payments reported to CMS, 2019-2025
14 companies · $474 in 2025
The $474 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,176 · 2020: $249 · 2021: $138 · 2022: $443 · 2023: $2,925 · 2024: $160 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,990 · Food and Beverage: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,990.23 |
| Food and Beverage | $1,568.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,872.28 | 2019-2025 | Evos, Trigen, Trigen Intertan |
| Medical Device Business Services, INC. | $1,045.99 | 2019 | |
| Depuy Synthes Sales INC. | $531.01 | 2019-2022 | |
| Stryker Corporation | $340.26 | 2022-2025 | T2 Alpha |
| Si-Bone, INC. | $159.66 | 2023 | |
| Djo, LLC | $158.25 | 2019 | |
| Curvafix, INC. | $155.25 | 2022 | |
| Osteocentric Technologies, INC. | $143.11 | 2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Ethicon US, LLC | $64.03 | 2019-2020 | |
| Orthofix Medical, INC. | $30.46 | 2021 | |
| Abbott Laboratories | $18.03 | 2020 | |
| Bioventus LLC | $17.93 | 2022 | |
| Bone Support INC. | $15.97 | 2024 | Cerament G, Ceramentbone Void Filler |
| Biocomposites INC | $12.35 | 2023 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Mcarthur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.